Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
16-bromoepiandrosterone
- Development stage
- Phase 1
- Lead developer
- Crede Capital Group
- Modality
- Small Molecules
- Administration
- Intramuscular Injection, Buccal (buccomucosal), Oral (investigational/preclinical)
01
Overview
16-Bromoepiandrosterone is a synthetic steroid and chemical analogue of dehydroepiandrosterone (DHEA), developed as an injectable formulation. It was selected for development after demonstrating antiretroviral activity in laboratory tests. Unlike DHEA, it lacks anabolic effects but amplifies immune and metabolic responses. The compound has been investigated for its potential to limit nonproductive inflammation, enhance protective immunity, and improve survival in infections such as HIV, malaria, tuberculosis, hepatitis B and C, cytomegalovirus, polio, influenza virus, and Cryptosporidium parvum. Its mechanism involves inhibition of glucose 6-phosphate dehydrogenase (G6PDH) and modulation of androgen receptor activity; it also affects cell proliferation through complex interactions with cellular receptors[1][2][3][4][5].
- Brand names
- ImmunitinInactivin
- Other names
- 16alpha-bromoepiandrosteroneInactivinEpi-Br16-Br-epi
02
Targets
AR (Adrenergic receptors)G6PD (Glucose-6-phosphate dehydrogenase)
Beyond the preview
Go deeper on 16-bromoepiandrosterone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 16-bromoepiandrosterone.